NCT05793905View on ClinicalTrials.gov

Buffered Anesthetic Solution in the Treatment of Mandibular Primary Molars

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

April 3, 2023

Conditions
Local Anesthesia
Interventions
COMBINATION_PRODUCT

Buffered lidocaine in inferior alveolar nerve block injection

Buffered Lidocaine 2% with epinephrine 1.80000 mixed with 1.8% sodium bicarbonate in IANB injection in the treatment of bilateral primary mandibular molars

DRUG

lidocaine 2% in inferior alveolar nerve block injection

Lidocaine 2% with epinephrine 1.80000 in IANB injection in the treatment of bilateral primary mandibular molars

Trial Locations (1)

Damascus P.O.Box 3062

College of dentistry., Damascus

All Listed Sponsors
lead

Damascus University

OTHER